{"entity":{"type":"insider","cik":"0001992595","url":"/insider/0001992595","json_url":"/insider/0001992595.json","name":"Pinto Joshua","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":4,"first":"2024-08-26","last":"2026-02-19","span_basis":"filed_date"},"name_variants":[{"name":"Pinto Joshua","source":"filing","n_filings":4,"first_seen":"2024-08-26","last_seen":"2026-02-19"}],"transactions":[{"id":5863051,"accession":"0001610717-26-000053","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000053","line_url":"/filing/0001610717-26-000053#line-1","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992595","owner_name":"Pinto Joshua","owner_display_name":"Pinto Joshua","owner_url":"/insider/0001992595","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5967.0,"shares_display":"5,967","price_per_share":3.535,"price_display":"3.54","price_state":"stated","total_value":21093.345,"total_display":"21,093.34","total_whole":"21,093","shares_owned_after":57783.0,"shares_owned_after_display":"57,783","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-17","filed_date":"2026-02-19","scope":"insider"},{"id":4823434,"accession":"0001610717-25-000027","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000027","line_url":"/filing/0001610717-25-000027#line-1","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992595","owner_name":"Pinto Joshua","owner_display_name":"Pinto Joshua","owner_url":"/insider/0001992595","role":"Officer (President)","role_mark":"O","role_mark_label":"Officer (President)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8048.0,"shares_display":"8,048","price_per_share":1.6746,"price_display":"1.67","price_state":"stated","total_value":13477.1808,"total_display":"13,477.18","total_whole":"13,477","shares_owned_after":76952.0,"shares_owned_after_display":"76,952","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-18","filed_date":"2025-02-20","scope":"insider"},{"id":3222347,"accession":"0001610717-24-000457","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000457","line_url":"/filing/0001610717-24-000457#line-1","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992595","owner_name":"Pinto Joshua","owner_display_name":"Pinto Joshua","owner_url":"/insider/0001992595","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15693.0,"shares_display":"15,693","price_per_share":11.394,"price_display":"11.39","price_state":"stated","total_value":178806.042,"total_display":"178,806.04","total_whole":"178,806","shares_owned_after":138965.0,"shares_owned_after_display":"138,965","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-27","filed_date":"2024-08-27","scope":"insider"},{"id":2363525,"accession":"0001610717-24-000456","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001610717-24-000456","line_url":"/filing/0001610717-24-000456#line-3","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992595","owner_name":"Pinto Joshua","owner_display_name":"Pinto Joshua","owner_url":"/insider/0001992595","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31642.0,"shares_display":"31,642","price_per_share":11.7751,"price_display":"11.78","price_state":"stated","total_value":372587.7142,"total_display":"372,587.71","total_whole":"372,588","shares_owned_after":154658.0,"shares_owned_after_display":"154,658","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-26","filed_date":"2024-08-26","scope":"insider"},{"id":2363522,"accession":"0001610717-24-000456","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001610717-24-000456","line_url":"/filing/0001610717-24-000456#line-2","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992595","owner_name":"Pinto Joshua","owner_display_name":"Pinto Joshua","owner_url":"/insider/0001992595","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24169.0,"shares_display":"24,169","price_per_share":11.5853,"price_display":"11.59","price_state":"stated","total_value":280005.1157,"total_display":"280,005.12","total_whole":"280,005","shares_owned_after":186300.0,"shares_owned_after_display":"186,300","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-23","filed_date":"2024-08-26","scope":"insider"},{"id":2363517,"accession":"0001610717-24-000456","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-24-000456","line_url":"/filing/0001610717-24-000456#line-1","is_derivative":false,"issuer_cik":"0001885522","issuer_name":"Neumora Therapeutics, Inc.","issuer_ticker":"NMRA","issuer_name_source":null,"issuer_url":"/issuer/0001885522","owner_cik":"0001992595","owner_name":"Pinto Joshua","owner_display_name":"Pinto Joshua","owner_url":"/insider/0001992595","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28496.0,"shares_display":"28,496","price_per_share":11.6321,"price_display":"11.63","price_state":"stated","total_value":331468.3216,"total_display":"331,468.32","total_whole":"331,468","shares_owned_after":210469.0,"shares_owned_after_display":"210,469","ownership_form":"I","is_10b5_1":null,"transaction_date":"2024-08-22","filed_date":"2024-08-26","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":6,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001885522","name":"Neumora Therapeutics, Inc.","url":"/issuer/0001885522","role":"Officer (President)","n_filings":4,"first_seen":"2024-08-26","last_seen":"2026-02-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001992595","retrieved_at":"2026-08-23T16:27:14+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}